CSI Market
Sign In | Register

Lifecore Biomedical Inc (LFCR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access LFCR Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Lifecore Biomedical Inc adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Sep 30 2025) (May 25 2025) (Feb 23 2025) (Nov 24 2024)
Operating Activities
Income-14.98
Depreciation & amortization2.31
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring Costs and Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.93
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Other Assets0.00
Share-based Compensation1.70
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest7.08
Gain Loss On Disposition Of Property-
Accounts Receivable Allowance For Credit Loss Reserve-
Goodwill And Intangible Asset Impairment-
Restructuring Settlement And Impairment Provisions-
Gains Losses On Restructuring Of Debt-
Depreciation Amortization Of Intangibles Debt Costs And Right Of Use Assets-
Gain Loss On Disposition Of Property Plant Equipment Restructuring-
Provision For Loan Losses Expensed-
Operating Lease Impairment Loss-
Capital Expenditures Incurred But Not Yet Paid-
Increase Decrease In Contract With Customer Asset-0.21
Income taxes0.00
Unrealized Gain (Loss) on Derivatives3.16
Increase (Decrease) in Receivables6.77
Increase (Decrease) in Accounts Payable1.43
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-3.65
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital0.21
Other Noncash Income (Expense)-0.05
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities4.70
Investing Activities
Capital Expenditures-1.12
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Deposit On Capital Lease-
Payments For Issuance Of Notes Receivable-
Sale Net Working Capital Adjustment Investing Activities-
Payments To Acquire Property Plant And Equipment Including Discontinued Operations-
Business Sale Net Working Capital Adjustments-
Loss On Disposition Of Business-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Sale of Equity Method Investments0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-1.12
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings36.40
Long-term debt - repayments-36.40
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-17.73
Earn Out Payment From Acquisition-
Purchase Of Noncontrolling Interests-
Payments For Purchase Of Noncontrolling Interest-
Finance Lease Principal Payments-
Proceeds From Long Term Customer Deposit-
Proceeds From Finance Lease Incentives-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents17.47
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.26
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow3.58
Total Cash Flow3.33
4 historic quarters locked

Sign in to unlock the full Lifecore Biomedical Inc cash flow history.

Sign In Create Free Account

About Lifecore Biomedical Inc De Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001005286-26-000033

Figures are derived from filed reports and may be restated. Historical data is subject to revision.